Follow The Filings

ANRO Alto Neuroscience Inc.

Health Care, filed as ALTO NEUROSCIENCE INC (COM SHS), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 exit

In 2026 Q2 Polen Capital Management sold out of Alto Neuroscience.

Who owns ANRO

Sorted by value, long equity only, as of 2026 Q2.

History
Polen Capital Management exited 2026 Q2 Last 2026 Q1 <0.01% Exit 0.00% 16,613 $373K History

0 current, 1 exited last period, options excluded

Insider trades

Open-market buys and sales by ANRO's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ANRO insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $3.6M sold by 1 insider under 10b5-1 plans
  1. Nicholas Conrad Smith CFO
    Planned sale
    $3.6M 134,886 shares at $26.45 85% of stake
    Traded Sep 29–30 Filed Oct 1
    ↗

Also filed in the last 12 months, not counted as buying or selling: 4 option exercises, 2 share withholdings for taxes, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
SCHEDULE 13G — Filing Doc
8-K 5.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
424B5 Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 2.02,8.01 Filing Doc
8-K 5.02 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc

Source: SEC EDGAR submissions, updated 2 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2024 FY2025
Net income -$61.43M -$63.24M

Balance sheet

Metric FY2024 FY2025
Total current assets $169.34M $177.72M
Total non-current assets * $8.2M $6.97M
Total assets $177.54M $184.69M
Total current liabilities $10.01M $11.32M
Total non-current liabilities * $16.07M $22.22M
Total equity $151.46M $151.14M

Cash flow

Metric FY2024 FY2025
Cash from operations -$47.42M -$51.77M
Cash from investing -$2.08M -$0.024M
Cash from financing $135.69M $60.08M
Net change in cash $86.18M $8.26M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.